Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the interest coverage ratio high or low?
The interest coverage ratio of -1568.80x is in line with its 2-year average of -1642.06x, near the high end of its 2-year range (-5740.00x–-65.64x).
As of the fiscal period ended Friday, December 31, 2021. 44.57% above its 12-month average of -2830.08x.
Reported quarterly interest coverage; no daily interpolation. Q4 FY2021 (2021-12-31): -1568.80x.
INTEREST COVERAGE RATIO
-1568.80x
INTEREST COVERAGE RATIO AVG TTM
-2830.08x
INTEREST COVERAGE RATIO AVG 3Y
N/A
INTEREST COVERAGE RATIO AVG 5Y
N/A
INTEREST COVERAGE RATIO AVG 10Y
N/A
INTEREST COVERAGE RATIO AVG 15Y
N/A
INTEREST COVERAGE RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
+44.57%
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-4.23x
median of 360 covered companies
CURRENT VS SECTOR MEDIAN
-36987.47%
vs the sector median at left
Immunome, Inc.
Market Cap
$1.98B
Interest Coverage Ratio
-1568.80x
TTM Avg
-2830.08x
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$2.00B
Interest Coverage Ratio
24.23x
TTM Avg
24.23x
3Y Avg
24.23x
5Y Avg
24.23x
Market Cap
$2.02B
Interest Coverage Ratio
-1.02x
TTM Avg
0.38x
3Y Avg
0.38x
5Y Avg
0.21x
Market Cap
$2.01B
Interest Coverage Ratio
371.93x
TTM Avg
1006.04x
3Y Avg
1006.04x
5Y Avg
1006.04x
Market Cap
$2.02B
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$1.94B
Interest Coverage Ratio
-1.54x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$2.03B
Interest Coverage Ratio
N/A
TTM Avg
1.77x
3Y Avg
2.62x
5Y Avg
35.29x
Market Cap
$2.03B
Interest Coverage Ratio
4.32x
TTM Avg
4.32x
3Y Avg
4.32x
5Y Avg
4.32x
| NAME | MARKET CAP | INTEREST COVERAGE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Immunome, Inc. (IMNM) | $1.98B | -1568.80x | -2830.08x | N/A | N/A |
| Aurinia Pharmaceuticals Inc. (AUPH)vs › | $2.00B | 24.23x | 24.23x | 24.23x | 24.23x |
| AxoGen, Inc. (AXGN)vs › | $2.02B | -1.02x | 0.38x | 0.38x | 0.21x |
| Inspire Medical Systems, Inc. (INSP)vs › | $2.01B | 371.93x | 1006.04x | 1006.04x | 1006.04x |
| Mineralys Therapeutics, Inc. (MLYS)vs › | $2.02B | N/A | N/A | N/A | N/A |
| Establishment Labs Holdings Inc. (ESTA)vs › | $1.94B | -1.54x | N/A | N/A | N/A |
| Azenta, Inc. (AZTA)vs › | $2.03B | N/A | 1.77x | 2.62x | 35.29x |
| BioCryst Pharmaceuticals, Inc. (BCRX)vs › | $2.03B | 4.32x | 4.32x | 4.32x | 4.32x |
| Alvotech (ALVO)vs › | $2.07B | 0.52x | 0.48x | 0.48x | 0.48x |
| BioLife Solutions, Inc. (BLFS)vs › | $1.89B | -0.40x | 732.40x | 732.40x | 732.40x |
Interest Coverage
-1568.8x
Debt/Equity
0.01
Current Ratio
15.08
Formula: Interest Coverage = EBIT / Interest Expense
Reference ranges:
Note: Interest coverage should be compared with historical interest expense, operating income, and industry capital structure.
Interest Coverage = EBIT / Interest Expense
The interest coverage ratio measures operating earnings relative to interest expense.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | INTEREST COVERAGE RATIO |
|---|---|
| 2021-12-31 | -1568.80x |
| 2021-09-30 | -2574.33x |
| 2021-06-30 | -5740.00x |
| 2021-03-31 | -3897.00x |
| 2020-12-31 | -370.27x |
| 2020-09-30 | -281.80x |
| 2020-03-31 | -120.68x |
| 2019-12-31 | -65.64x |
| 2019-09-30 | -160.00x |
